Table 3.
ID | Histo‐Nr. | Histological diagnosis | Fixation type | Fixation time (days) | Amplifiable DNA reference genes (bp) | Amplifiable RNA reference genes (bp) |
---|---|---|---|---|---|---|
1 | N1420‐08 | GBM | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 1 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238 | |||
2 | N225‐09 | GBM | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 1 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238 | |||
3 | N234‐09 | GBM | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 1 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238, 377 | |||
4 | N1366‐08 | Meningothelial meningioma | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 1 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238, 377 | |||
5 | N1369‐08 | Metastasis (carcinoma) | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 1 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238, 377 | |||
6 | N392‐09 | GBM | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 2 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 2 | 100, 200, 300, 400, 600 | 238 | |||
7 | N401‐09 | AOA | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 2 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 2 | 100, 200, 300, 400, 600 | 238, 377 | |||
8 | N98‐09 | Medulloblastoma | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 3 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 1 | 100, 200, 300, 400, 600 | 238 | |||
9 | N1509‐08 | GBM | Frozen | 100, 200, 300, 400, 600 | na | |
RCL2 | 3 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 3 | 100, 200, 300, 400, 600 | 238 | |||
10 | N1377‐08 | DA | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 3 | 100, 200, 300, 400, 600 | 238, 377 | |||
Formalin | 3 | 100, 200, 300, 400, 600 | 238 | |||
11 | N1492‐08 | DA | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 3 | 100, 200, 300, 400, 600 | 238, 377 | |||
Formalin | 3 | 100, 200, 300, 400, 600 | 238 | |||
12 | N87‐09 | AA | Frozen | 100, 200, 300, 400, 600 | 238, 295, 377 | |
RCL2 | 6 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 3 | 100, 200, 300, 400 | 238 | |||
13 | N191‐09 | PXA | Frozen | 100, 200, 300, 400, 600 | na | |
RCL2 | 8 | 100, 200, 300, 400, 600 | 238, 295, 377 | |||
Formalin | 8 | 100, 200, 300, 400 | 238 |
Nucleic acid degradation was estimated by evaluation of the length of reference DNA fragments generated in a multiplex PCR system, respectively. In the presence of undegraded DNA, reference DNA fragments of 100, 200, 300, 400 and 600 bp are expected. In the presence of undegraded RNA, reference gene amplificates of 238, 295 and 377 bp are expected. Failure to amplify reference DNA fragments indicates DNA or RNA degradation, respectively.